Full Breakdown
New York City Health + Hospitals Ends Contract with Palantir Amid Controversy
3/27/2026, 8:07:27 AM
Overview of the Decision
New York City’s public hospital system, NYC Health + Hospitals, has announced it will not renew its contract with Palantir Technologies, a data analytics and AI firm, as the agreement is set to expire in October 2026. This decision follows mounting criticism regarding Palantir's involvement in immigration enforcement and surveillance activities. Dr. Mitchell Katz, the president of NYC Health + Hospitals, confirmed this decision during a recent city council hearing, stating that the contract was always intended to be short-term and emphasizing that there had been no incidents involving data sharing with U.S. Immigration and Customs Enforcement (ICE).
Contract Details and Implications
Since November 2023, NYC Health + Hospitals has paid Palantir nearly $4 million for services aimed at optimizing revenue cycles, particularly in recovering funds from Medicaid and other public benefits. The contract allowed Palantir to access de-identified patient data, raising concerns among privacy advocates about potential misuse. In response to these concerns, NYC Health + Hospitals stated that it plans to transition to in-house systems that will not involve Palantir's technology after the contract ends.
Activist Response and Campaigns
The decision to end the contract has been hailed as a victory by various activist groups, including the American Friends Service Committee and the national nurses union. These organizations have campaigned against Palantir's contracts with government agencies, arguing that the company's technology facilitates ICE's surveillance and deportation efforts. Activists have been vocal in their opposition, asserting that Palantir's involvement in healthcare is inappropriate given its role in military and immigration enforcement.
Kenny Morris, an organizer with the American Friends Service Committee, stated, “Palantir makes money by enabling mass violence in the U.S. and around the world. They should have no place in our hospitals.” This sentiment reflects broader concerns about the ethical implications of using technology from a company associated with controversial government practices.
Broader Context in the UK
As NYC Health + Hospitals prepares to sever ties with Palantir, the company faces similar scrutiny in the UK, where it has a £330 million contract with the National Health Service (NHS). Health officials in the UK are worried that the controversy surrounding Palantir could hinder the rollout of its data systems across the country. Critics, including the health justice charity Medact, have raised alarms about the potential for data-driven abuses of power, echoing concerns voiced by activists in New York.
Official Statements and Responses
In defense of the contract, Dr. Katz emphasized that there was an “absolute firewall” preventing Palantir from sharing patient information with ICE, asserting that the hospital system had not experienced any issues. However, privacy experts have expressed skepticism about the effectiveness of de-identification practices, warning that advancements in AI could make it easier to re-identify individuals from de-identified data.
Conclusion and Future Actions
The decision by NYC Health + Hospitals to discontinue its contract with Palantir is seen as a significant step in addressing community concerns about data privacy and ethical governance. Activists are hopeful that this move will inspire similar actions in the UK, where campaigns against Palantir's involvement in the NHS are gaining momentum. As the situation evolves, both the NYC and UK health systems will likely continue to face scrutiny regarding their partnerships with technology firms like Palantir.
Verbatim Quotes
- “Palantir makes money by enabling mass violence in the U.S. and around the world. They should have no place in our hospitals, our pension funds, or our government,” — Kenny Morris, Organizer, American Friends Service Committee
- “We haven’t had any problems,” — Dr. Mitchell Katz, President, NYC Health + Hospitals
- “As campaigners in New York have shown, workers and communities can hold our health institutions accountable and push them to make the right choice.” — Dr. Rhiannon Mihranian Osborne, Corporate Campaigns Lead, Medact
